Drug Trial Radar · NCT00806208
Trial for Evaluation of Safety of Escalating Dose Levels of MEDI-507 in Patients for Treatment of at Least Grade II Graft-Versus-Host Disease (GvHD)
Last checked: Nov 20, 2026Latest source record: Dec 11, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
34
Actual
Start
Jan 1999
Primary completion
Jan 2000
Study completion Mar 2000
Sponsor
- Lead sponsor
- MedImmune LLCAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Dec 10, 2008
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
A trial to assess safety of four doses of MEDI 507 combined with another drug for initial treatment of at least Grade II acute Graft-vs-Host Disease in recipients.
Conditions
- Graft-Versus-Host Disease
Interventions
MEDI-507Drug
0.012 mg/kg MEDI 507 and Methylprednisolone
MEDI-507Drug
0.04 mg/kg MEDI 507 and Methylprednisolone
MEDI-507Drug
0.12 mg/kg MEDI 507 and Methylprednisolone
MEDI-507Drug
0.4 mg/kg MEDI 507 and Methylprednisolone
PlaceboOther
Placebo IV (alternative) study days 0, 3,6, and 9
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety; first infusion of study drugTime frame: Through Study Day 44
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Washington University Medical Center
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
Baylor Institute of Transplant Sciences
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.